CINF
53
2
SLB
55
2
APD
59
2
TDC
80
4
WM
79
3
DNB
82
4
NDAQ
62
2
INTC
33
-2
AIV
72
2
VTR
47
-7
MLM
57
6
CF
57
-2
HD
57
2
WAT
55
2
LMT
34
2
DE
63
3
MTB
67
2
HSIC
56
5
FTI
81
5
BAC
53
3
CINF
53
2
SLB
55
2
APD
59
2
TDC
80
4
WM
79
3
DNB
82
4
NDAQ
62
2
INTC
33
-2
AIV
72
2
VTR
47
-7
MLM
57
6
CF
57
-2
HD
57
2
WAT
55
2
LMT
34
2
DE
63
3
MTB
67
2
HSIC
56
5
FTI
81
5
BAC
53
3
Financhill
Back

CRISPR Therapeutics AG Vs. NLS Pharmaceutics Industry Stock Comparison

Sell
45

CRSP
CRISPR Therapeutics AG

Last Price:
47.89
Seasonality Move:
12.87%
Sell
27

NLSP
NLS Pharmaceutics

Last Price:
3.48
Seasonality Move:
43.45%
Sell
45
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $47.88. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
NLS Pharmaceutics (NLSP) is a Sell

Is NLS Pharmaceutics a Buy, Sell or Hold?

  • The current NLS Pharmaceutics [NLSP] share price is $3.43. The Score for NLSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $47.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NLSP Stock Price Chart

What is NLS Pharmaceutics's stock price today?

  • The NLS Pharmaceutics share price today is $3.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 48.07 Sell
Chaikin Money Flow: 1329489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.76 - 51) Sell
Bollinger Bands (100): (45.56 - 53.76) Sell

NLSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 39.11 Sell
Chaikin Money Flow: -22778 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.4 - 4.36) Sell
Bollinger Bands (100): (4.21 - 7.55) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.45 Buy
20-day SMA: 49.2 Sell
50-day SMA: 47.99 Sell
200-day SMA: 57.15 Sell
8-day EMA: 47.81 Buy
20-day EMA: 48.44 Sell
50-day EMA: 48.6 Sell
200-day EMA: 53.27 Sell

NLSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.31 Buy
20-day SMA: 3.72 Sell
50-day SMA: 4.51 Sell
200-day SMA: 7.27 Sell
8-day EMA: 3.42 Buy
20-day EMA: 3.73 Sell
50-day EMA: 4.47 Sell
200-day EMA: 9.25 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.

NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NLS Pharmaceutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):